Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street ...

Abbott said that an ongoing multisite clinical study indicated that its rapid COVID-19 test was ... missed at least a third of positive cases detected with a rival test and as much as 48% when ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.